连续三次给药及持续用药期间酒石酸麦角胺的全身可用性。 - Suppr

Suppr

超能文献

Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

作者信息

Ala-Hurula V, Myllylä V V, Arvela P, Kärki N T, Hokkanen E

出版信息

Eur J Clin Pharmacol. 1979 Nov;16(5):355-60. doi: 10.1007/BF00605636.

DOI:10.1007/BF00605636

PMID:520404

Abstract

摘要

相似文献

Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.连续三次给药及持续用药期间酒石酸麦角胺的全身可用性。

Eur J Clin Pharmacol. 1979 Nov;16(5):355-60. doi: 10.1007/BF00605636.

Systemic availability of ergotamine tartrate in continuous medication.连续用药时酒石酸麦角胺的全身可用性。

Ups J Med Sci Suppl. 1980;31:20-2.

Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.单次及重复口服剂量后，健康受试者中酒石酸麦角胺的全身可用性。

Ups J Med Sci Suppl. 1980;31:7-9.

Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.偏头痛患者静脉注射和肌肉注射麦角胺后的药代动力学。

Eur J Clin Pharmacol. 1982;23(3):235-40. doi: 10.1007/BF00547560.

Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.口服、直肠给药和肌肉注射后酒石酸麦角胺的全身可用性。

Eur J Clin Pharmacol. 1979 Feb 19;15(1):51-5. doi: 10.1007/BF00563557.

The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve.单剂量酒石酸麦角胺对偏头痛患者外周动脉的影响：方法学方面及时间效应曲线

Acta Pharmacol Toxicol (Copenh). 1980 Aug;47(2):151-6. doi: 10.1111/j.1600-0773.1980.tb01855.x.

Ergotamine-induced anorectal strictures: report of five cases.麦角胺所致肛门直肠狭窄：5例报告

Dis Colon Rectum. 2002 Feb;45(2):271-2. doi: 10.1007/s10350-004-6160-x.

Ketoprofen and ergotamine in acute migraine.

J Intern Med. 1992 May;231(5):551-4. doi: 10.1111/j.1365-2796.1992.tb00973.x.

[Use of ergotamine tartrate as a suppository in migraine].

Nord Med. 1968 Jul 18;80(29):942-4.

A new look at the use of ergotamine.麦角胺使用的新视角。

Drugs. 1976 Dec;12(6):449-53. doi: 10.2165/00003495-197612060-00004.

引用本文的文献

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy.干预先兆期以预防偏头痛：药物治疗的前景。

CNS Drugs. 2024 Jul;38(7):533-546. doi: 10.1007/s40263-024-01091-2. Epub 2024 May 31.

Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.发作期缺乏与脑实质的结合表明在硝酸甘油诱发的偏头痛期间，血脑屏障对11C-二氢麦角胺保持完整。

Brain. 2016 Jul;139(Pt 7):1994-2001. doi: 10.1093/brain/aww096. Epub 2016 May 27.

Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity.麦角生物碱透过血脑屏障的体外渗透性及其对屏障完整性的影响。

Mol Nutr Food Res. 2012 Mar;56(3):475-85. doi: 10.1002/mnfr.201100431. Epub 2011 Dec 7.

Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.偏头痛患者静脉注射和肌肉注射麦角胺后的药代动力学。

Eur J Clin Pharmacol. 1982;23(3):235-40. doi: 10.1007/BF00547560.

Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.偏头痛患者中麦角胺的药代动力学与临床疗效之间的相关性。

Eur J Clin Pharmacol. 1982;21(5):397-402. doi: 10.1007/BF00542326.

Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.偏头痛患者口服和直肠给药后酒石酸麦角胺的生物利用度较低。

Br J Clin Pharmacol. 1983 Dec;16(6):695-9. doi: 10.1111/j.1365-2125.1983.tb02243.x.

Rectal drug administration: clinical pharmacokinetic considerations.直肠给药：临床药代动力学考量

Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311. doi: 10.2165/00003088-198207040-00002.

Ergotamine abuse and extra-hepatic portal hypertension.麦角胺滥用与肝外门静脉高压症

Postgrad Med J. 1985 May;61(715):461-3. doi: 10.1136/pgmj.61.715.461.

Clinical pharmacokinetics of ergotamine in migraine and cluster headache.麦角胺在偏头痛和丛集性头痛中的临床药代动力学。

Clin Pharmacokinet. 1985 Jul-Aug;10(4):334-52. doi: 10.2165/00003088-198510040-00004.

Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.健康志愿者口服和直肠给药后麦角胺的药代动力学。

Eur J Clin Pharmacol. 1986;30(3):331-4. doi: 10.1007/BF00541538.

本文引用的文献

[About the fate of natural and dihydrogenated ergot alkaloids in the organism].[关于天然和二氢麦角生物碱在生物体内的命运]

Schweiz Med Wochenschr. 1947 Nov 1;77(44):1161-3.

Ergotamine tolerance in patients with migraine.

J Am Med Assoc. 1955 Mar 12;157(11):881-4. doi: 10.1001/jama.1955.02950280005002.

Ergotamine induced headaches in migrainous patients.麦角胺诱发偏头痛患者头痛。

Headache. 1973 Jul;13(2):65-7. doi: 10.1111/j.1526-4610.1973.hed1302065.x.

A new look at the use of ergotamine.麦角胺使用的新视角。

Drugs. 1976 Dec;12(6):449-53. doi: 10.2165/00003495-197612060-00004.

Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.离体犬脑动脉和外周动脉对麦角胺的反应性。

Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):113-8. doi: 10.1007/BF00498580.

Further studies concerning the toxicity of ingested ergot sclerotia (Claviceps purpurea) to young and growing pigs.

Res Vet Sci. 1977 Mar;22(2):146-50.

9-10-dihydroergotamine: production of antibodies and radioimmunoassay.9-10-二氢麦角胺：抗体的产生及放射免疫测定

Experientia. 1976 Feb 15;32(2):234-6. doi: 10.1007/BF01937784.

Toxic effects of ergotamine used for migraine.用于偏头痛治疗的麦角胺的毒性作用。

Headache. 1978 May;18(2):95-8. doi: 10.1111/j.1526-4610.1978.hed1802095.x.

Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.口服、直肠给药和肌肉注射后酒石酸麦角胺的全身可用性。

Eur J Clin Pharmacol. 1979 Feb 19;15(1):51-5. doi: 10.1007/BF00563557.

Migraine. I. Classification and pathogenesis.偏头痛。一、分类与发病机制。

JAMA. 1978 Jun 2;239(22):2380-3. doi: 10.1001/jama.239.22.2380.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验